Sichenzia Ross Ference LLP Represents BriaCell Therapeutics Corp. in $27.2 Million Private Placement By Sichenzia Ross Ference LLP | June 9, 2021 BriaCell Therapeutics Corp. $27,200,000 Common Stock and Warrants June 2021 Read More
Sichenzia Ross Ference LLP Represents BriaCell Therapeutics Corp. in Nasdaq listing and $25 Million Public Offering By Sichenzia Ross Ference LLP | February 26, 2021 BriaCell Therapeutics Corp. $25,000,000 Common Stock and Warrants February 2021 Read More
